17-51154262-C-G

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_198175.1(NME1):​c.-112C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 945,918 control chromosomes in the GnomAD database, including 71,543 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.39 ( 11172 hom., cov: 30)
Exomes 𝑓: 0.39 ( 60371 hom. )

Consequence

NME1
NM_198175.1 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.19
Variant links:
Genes affected
NME1-NME2 (HGNC:33531): (NME1-NME2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring NME1 and NME2 genes. The significance of this read-through transcription and the function of the resulting protein product have not yet been determined. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Nov 2010]
NME1 (HGNC:7849): (NME/NM23 nucleoside diphosphate kinase 1) This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of 'A' (encoded by this gene) and 'B' (encoded by NME2) isoforms. Mutations in this gene have been identified in aggressive neuroblastomas. Two transcript variants encoding different isoforms have been found for this gene. Co-transcription of this gene and the neighboring downstream gene (NME2) generates naturally-occurring transcripts (NME1-NME2), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-51154262-C-G is Benign according to our data. Variant chr17-51154262-C-G is described in ClinVar as [Benign]. Clinvar id is 2688272.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.397 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NME1NM_000269.3 linkuse as main transcriptc.-5+600C>G intron_variant ENST00000393196.8 NP_000260.1 P15531-1A0A384MTW7
NME1NM_198175.1 linkuse as main transcriptc.-112C>G 5_prime_UTR_variant 2/6 NP_937818.1 P15531-2
NME1-NME2NM_001018136.3 linkuse as main transcriptc.-5+600C>G intron_variant NP_001018146.1 P22392-2
NME1-NME2NR_037149.2 linkuse as main transcriptn.142C>G non_coding_transcript_exon_variant 2/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NME1-NME2ENST00000555572 linkuse as main transcriptc.-112C>G 5_prime_UTR_variant 2/92 ENSP00000451932.1 Q32Q12
NME1ENST00000393196.8 linkuse as main transcriptc.-5+600C>G intron_variant 1 NM_000269.3 ENSP00000376892.3 P15531-1

Frequencies

GnomAD3 genomes
AF:
0.385
AC:
58267
AN:
151184
Hom.:
11155
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.374
Gnomad AMI
AF:
0.408
Gnomad AMR
AF:
0.406
Gnomad ASJ
AF:
0.407
Gnomad EAS
AF:
0.375
Gnomad SAS
AF:
0.305
Gnomad FIN
AF:
0.363
Gnomad MID
AF:
0.394
Gnomad NFE
AF:
0.396
Gnomad OTH
AF:
0.394
GnomAD4 exome
AF:
0.387
AC:
307602
AN:
794614
Hom.:
60371
Cov.:
11
AF XY:
0.383
AC XY:
161395
AN XY:
421316
show subpopulations
Gnomad4 AFR exome
AF:
0.372
Gnomad4 AMR exome
AF:
0.399
Gnomad4 ASJ exome
AF:
0.400
Gnomad4 EAS exome
AF:
0.362
Gnomad4 SAS exome
AF:
0.318
Gnomad4 FIN exome
AF:
0.374
Gnomad4 NFE exome
AF:
0.398
Gnomad4 OTH exome
AF:
0.395
GnomAD4 genome
AF:
0.385
AC:
58322
AN:
151304
Hom.:
11172
Cov.:
30
AF XY:
0.381
AC XY:
28169
AN XY:
73864
show subpopulations
Gnomad4 AFR
AF:
0.374
Gnomad4 AMR
AF:
0.406
Gnomad4 ASJ
AF:
0.407
Gnomad4 EAS
AF:
0.375
Gnomad4 SAS
AF:
0.306
Gnomad4 FIN
AF:
0.363
Gnomad4 NFE
AF:
0.396
Gnomad4 OTH
AF:
0.399
Alfa
AF:
0.396
Hom.:
1441
Bravo
AF:
0.391
Asia WGS
AF:
0.359
AC:
1246
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 27% of patients studied by a panel of primary immunodeficiencies. Number of patients: 26. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.65
DANN
Benign
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34431255; hg19: chr17-49231623; COSMIC: COSV50147122; COSMIC: COSV50147122; API